Class II · ModerateActive recall
Morphine Sulfate Extended-Release Tablets 30 mg
Could cause temporary or reversible harm; serious harm is unlikely.
Does this affect you?
Check your lot numberLot# FG13996, Exp 09/30/2025
Where it was soldNationwide in the USA
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Failed Impurities/Degradation Specification
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
Made byMayne Pharma, Greenville, NC 27834
| Distributed by / for | Dr. Reddy's Laboratories, Inc. |
| NDC | 51862-186-01 |
Show the full FDA record
| Full product label | Morphine Sulfate Extended-Release Tablets 30 mg, 100-count bottles, Rx Only, Manufactured by Mayne Pharma, Greenville, NC 27834, NDC 51862-186-01. |
| Recalling firm | Dr. Reddy's Laboratories, Inc. |
| Distribution | Nationwide in the USA |
| Quantity | 532 100-count bottles |
| Recall initiated | 2024-10-22 |
| Report date | 2024-11-13 |
| Recall completed | — |
| Recall number | D-0037-2025 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.